Mei Chen1, Weiming Xia1,2. 1. Geriatric Research Education Clinical Center, Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA, USA. 2. Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA.
Abstract
BACKGROUND: Alzheimer's disease (AD) is the most prevalent form of dementia with two pathological hallmarks of tau-containing neurofibrillary tangles and amyloid-β protein (Aβ)-containing neuritic plaques. Although Aβ and tau have been explored as potential biomarkers, levels of these pathological proteins in blood fail to distinguish AD from healthy control subjects. OBJECTIVE: We aim to discover potential plasma proteins associated with AD pathology by performing tandem mass tag (TMT)-based quantitative proteomic analysis of proteins from peripheral and central nervous system compartments. METHODS: We performed comparative proteomic analyses of plasma collected from AD patients and cognitively normal subjects. In addition, proteomic profiles from the inferior frontal cortex, superior frontal cortex, and cerebellum of postmortem brain tissue from five AD patients and five non-AD controls were compared with plasma proteomic profiles to search for common biomarkers. Liquid chromatography-mass spectrometry was used to analyze plasma and brain tissue labeled with isobaric TMT for relative protein quantification. RESULTS: Our results showed that the proteins in complement coagulation cascade and interleukin-6 signaling were significantly altered in both plasma and brains of AD patients. CONCLUSION: Our results demonstrate the relevance in immune responses between the peripheral and central nervous systems. Those differentially regulated plasma proteins are explored as candidate biomarker profiles that illustrate chronic neuroinflammation in brains of AD patients.
BACKGROUND: Alzheimer's disease (AD) is the most prevalent form of dementia with two pathological hallmarks of tau-containing neurofibrillary tangles and amyloid-β protein (Aβ)-containing neuritic plaques. Although Aβ and tau have been explored as potential biomarkers, levels of these pathological proteins in blood fail to distinguish AD from healthy control subjects. OBJECTIVE: We aim to discover potential plasma proteins associated with AD pathology by performing tandem mass tag (TMT)-based quantitative proteomic analysis of proteins from peripheral and central nervous system compartments. METHODS: We performed comparative proteomic analyses of plasma collected from AD patients and cognitively normal subjects. In addition, proteomic profiles from the inferior frontal cortex, superior frontal cortex, and cerebellum of postmortem brain tissue from five AD patients and five non-AD controls were compared with plasma proteomic profiles to search for common biomarkers. Liquid chromatography-mass spectrometry was used to analyze plasma and brain tissue labeled with isobaric TMT for relative protein quantification. RESULTS: Our results showed that the proteins in complement coagulation cascade and interleukin-6 signaling were significantly altered in both plasma and brains of AD patients. CONCLUSION: Our results demonstrate the relevance in immune responses between the peripheral and central nervous systems. Those differentially regulated plasma proteins are explored as candidate biomarker profiles that illustrate chronic neuroinflammation in brains of AD patients.
Entities:
Keywords:
Alzheimer’s disease; biomarker; mass spectrometry; plasma; quantitative proteomics; tandem mass tag (TMT)
Authors: Ana Griciuc; Alberto Serrano-Pozo; Antonio R Parrado; Andrea N Lesinski; Caroline N Asselin; Kristina Mullin; Basavaraj Hooli; Se Hoon Choi; Bradley T Hyman; Rudolph E Tanzi Journal: Neuron Date: 2013-04-25 Impact factor: 17.173
Authors: Oskar Hansson; Henrik Zetterberg; Peder Buchhave; Elisabet Londos; Kaj Blennow; Lennart Minthon Journal: Lancet Neurol Date: 2006-03 Impact factor: 44.182
Authors: Hedieh Shahpasand-Kroner; Hans-W Klafki; Chris Bauer; Johannes Schuchhardt; Melanie Hüttenrauch; Martina Stazi; Caroline Bouter; Oliver Wirths; Jonathan Vogelgsang; Jens Wiltfang Journal: Alzheimers Res Ther Date: 2018-12-08 Impact factor: 6.982
Authors: Sarah Westwood; Alison L Baird; Sneha N Anand; Alejo J Nevado-Holgado; Andrey Kormilitzin; Liu Shi; Abdul Hye; Nicholas J Ashton; Angharad R Morgan; Isabelle Bos; Stephanie J B Vos; Susan Baker; Noel J Buckley; Mara Ten Kate; Philip Scheltens; Charlotte E Teunissen; Rik Vandenberghe; Silvy Gabel; Karen Meersmans; Sebastiaan Engelborghs; Ellen E De Roeck; Kristel Sleegers; Giovanni B Frisoni; Olivier Blin; Jill C Richardson; Régis Bordet; José L Molinuevo; Lorena Rami; Anders Wallin; Petronella Kettunen; Magda Tsolaki; Frans Verhey; Alberto Lléo; Isabel Sala; Julius Popp; Gwendoline Peyratout; Pablo Martinez-Lage; Mikel Tainta; Peter Johannsen; Yvonne Freund-Levi; Lutz Frölich; Valerija Dobricic; Cristina Legido-Quigley; Lars Bertram; Frederik Barkhof; Henrik Zetterberg; B Paul Morgan; Johannes Streffer; Pieter Jelle Visser; Simon Lovestone Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472
Authors: A Hye; S Lynham; M Thambisetty; M Causevic; J Campbell; H L Byers; C Hooper; F Rijsdijk; S J Tabrizi; S Banner; C E Shaw; C Foy; M Poppe; N Archer; G Hamilton; J Powell; R G Brown; P Sham; M Ward; S Lovestone Journal: Brain Date: 2006-11 Impact factor: 13.501
Authors: R Babapour Mofrad; M Del Campo; C F W Peeters; L H H Meeter; H Seelaar; M Koel-Simmelink; I H G B Ramakers; H A M Middelkoop; P P De Deyn; J A H R Claassen; J C van Swieten; C Bridel; J J M Hoozemans; P Scheltens; W M van der Flier; Y A L Pijnenburg; Charlotte E Teunissen Journal: Acta Neuropathol Commun Date: 2022-10-22 Impact factor: 7.578
Authors: Artur Schumacher-Schuh; Andrei Bieger; Wyllians V Borelli; Makayla K Portley; Paula Saffie Awad; Sara Bandres-Ciga Journal: Front Neurol Date: 2022-01-31 Impact factor: 4.003
Authors: Alexey S Kononikhin; Natalia V Zakharova; Savva D Semenov; Anna E Bugrova; Alexander G Brzhozovskiy; Maria I Indeykina; Yana B Fedorova; Igor V Kolykhalov; Polina A Strelnikova; Anna Yu Ikonnikova; Dmitry A Gryadunov; Svetlana I Gavrilova; Evgeny N Nikolaev Journal: Int J Mol Sci Date: 2022-07-18 Impact factor: 6.208